To avoid that issue, Dr. Muller envisions thetechnology as part of a strategy in which people would first be identified as at risk through a genetic test and a noninvasive imaging test such as a CT scan before being referred for the spectroscopy analysis.
He is a firm believer in technology and is often seen at a Test crouched over a laptop, pouring through facts and figures and the finer detail of the game.